Skye Bioscience earnings were -$32.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SKYE earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$11.1M, up 13.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SKYE reported annual earnings of -$26.6M, with -29.4% growth.
What were Skye Bioscience's earnings last quarter?
On SKYE's earnings call on Invalid Date, Skye Bioscience (NASDAQ: SKYE) reported Q1 2025 earnings per share (EPS) of -$0.28, up 55.56% year over year. Total SKYE earnings for the quarter were -$11.10 million. In the same quarter last year, Skye Bioscience's earnings per share (EPS) was -$0.18.
As of the last Skye Bioscience earnings report, Skye Bioscience is currently losing money. Skye Bioscience's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$32.65 million, a 12.92% decrease year over year.
What was SKYE's earnings growth in the past year?
As of Skye Bioscience's earnings date in Invalid Date, Skye Bioscience's earnings has grown year over year. SKYE earnings in the past year totalled -$32.65 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.